SI1513532T1 - Sistemi za odstranjevanje priprav za transdermalno oddajanje za preprečevanje zlorabe učinkovin, ki jih vsebujejo - Google Patents
Sistemi za odstranjevanje priprav za transdermalno oddajanje za preprečevanje zlorabe učinkovin, ki jih vsebujejoInfo
- Publication number
- SI1513532T1 SI1513532T1 SI200330785T SI200330785T SI1513532T1 SI 1513532 T1 SI1513532 T1 SI 1513532T1 SI 200330785 T SI200330785 T SI 200330785T SI 200330785 T SI200330785 T SI 200330785T SI 1513532 T1 SI1513532 T1 SI 1513532T1
- Authority
- SI
- Slovenia
- Prior art keywords
- transdermal delivery
- delivery device
- active component
- contained
- active agents
- Prior art date
Links
- 230000037317 transdermal delivery Effects 0.000 title abstract 6
- 239000013543 active substance Substances 0.000 title 1
- 239000000853 adhesive Substances 0.000 abstract 2
- 230000001070 adhesive effect Effects 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000003999 initiator Substances 0.000 abstract 2
- 239000000758 substrate Substances 0.000 abstract 2
- 229920001577 copolymer Polymers 0.000 abstract 1
- 239000003431 cross linking reagent Substances 0.000 abstract 1
- 230000003292 diminished effect Effects 0.000 abstract 1
- 230000002743 euphoric effect Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 239000003402 opiate agonist Substances 0.000 abstract 1
- 239000003401 opiate antagonist Substances 0.000 abstract 1
- 238000006116 polymerization reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
- B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
- B09B3/00—Destroying solid waste or transforming solid waste into something useful or harmless
- B09B3/0075—Disposal of medical waste
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
- B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
- B09B2101/00—Type of solid waste
- B09B2101/65—Medical waste
- B09B2101/68—Transdermal patches
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Environmental & Geological Engineering (AREA)
- Addiction (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Processing Of Solid Wastes (AREA)
- Adhesives Or Adhesive Processes (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38780002P | 2002-06-10 | 2002-06-10 | |
PCT/US2003/018256 WO2003103673A1 (en) | 2002-06-10 | 2003-06-10 | Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein |
EP03757468A EP1513532B1 (en) | 2002-06-10 | 2003-06-10 | Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1513532T1 true SI1513532T1 (sl) | 2007-08-31 |
Family
ID=29736367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200330785T SI1513532T1 (sl) | 2002-06-10 | 2003-06-10 | Sistemi za odstranjevanje priprav za transdermalno oddajanje za preprečevanje zlorabe učinkovin, ki jih vsebujejo |
Country Status (22)
Country | Link |
---|---|
US (2) | US20040033255A1 (sl) |
EP (4) | EP1513532B1 (sl) |
JP (3) | JP4949625B2 (sl) |
KR (2) | KR101407131B1 (sl) |
CN (2) | CN101455649B (sl) |
AT (1) | ATE355061T1 (sl) |
AU (2) | AU2003251482A1 (sl) |
CA (1) | CA2488915C (sl) |
CY (1) | CY1107630T1 (sl) |
DE (1) | DE60312160T2 (sl) |
DK (1) | DK1513532T3 (sl) |
EA (1) | EA007240B1 (sl) |
ES (1) | ES2283812T3 (sl) |
IL (1) | IL165517A0 (sl) |
MX (1) | MXPA04012333A (sl) |
NO (1) | NO334455B1 (sl) |
NZ (1) | NZ537180A (sl) |
PT (1) | PT1513532E (sl) |
SI (1) | SI1513532T1 (sl) |
UA (1) | UA82194C2 (sl) |
WO (1) | WO2003103673A1 (sl) |
ZA (1) | ZA200409495B (sl) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040202717A1 (en) | 2003-04-08 | 2004-10-14 | Mehta Atul M. | Abuse-resistant oral dosage forms and method of use thereof |
US8790689B2 (en) * | 2003-04-30 | 2014-07-29 | Purdue Pharma L.P. | Tamper resistant transdermal dosage form |
EP1641441B1 (en) * | 2003-04-30 | 2014-03-12 | Purdue Pharma L.P. | Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer |
US7867511B2 (en) | 2004-01-23 | 2011-01-11 | Travanti Pharma Inc. | Abuse potential reduction in abusable substance dosage form |
US8535711B2 (en) | 2004-01-23 | 2013-09-17 | Teikoku Pharma Usa, Inc. | Medication disposal system |
RS50963B (sr) * | 2004-02-23 | 2010-10-31 | Euro-Celtique S.A. | Opioidni transdermalni preparat otporan na zloupotrebu |
US20060045897A1 (en) * | 2004-08-27 | 2006-03-02 | Aso Corporation | Occlusive articles for wart treatment |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
US7780981B2 (en) | 2004-09-13 | 2010-08-24 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
WO2006069008A1 (en) * | 2004-12-22 | 2006-06-29 | Vesta Medical, Llc | Compositions and devices for inactivation of pharmaceuticals to facilitate waste disposal, and methods thereof |
US20070014839A1 (en) * | 2005-07-18 | 2007-01-18 | Stefan Bracht | Decomposer film for transdermal patches |
EP1968539A2 (en) * | 2005-12-13 | 2008-09-17 | Biodelivery Sciences International, Inc. | Abuse resistant transmucosal drug delivery device |
EP3067044B1 (en) | 2006-07-21 | 2019-03-27 | BioDelivery Sciences International, Inc. | Transmucosal delivery devices with enhanced uptake |
US20080226702A1 (en) * | 2007-03-16 | 2008-09-18 | Endo Pharmaceuticals, Inc. | Transdermal Delivery Form Disposal Systems and Methods |
EP2259780A2 (en) | 2008-02-28 | 2010-12-15 | Syntropharma Limited | Pharmaceutical composition comprising naltrexone |
JP2011515495A (ja) * | 2008-03-26 | 2011-05-19 | オールトランツ インコーポレイティド | オピエートアゴニスト及びアゴニスト−アンタゴニストの乱用抑制経皮製剤 |
DE202008004785U1 (de) * | 2008-04-04 | 2009-08-13 | Grünenthal GmbH | Entsorgungsvorrichtung |
US8329210B2 (en) * | 2008-09-23 | 2012-12-11 | Pharmapatch, Llc | Twin transdermal drug delivery patch |
TWI630208B (zh) | 2008-12-08 | 2018-07-21 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
US8507182B2 (en) * | 2009-06-09 | 2013-08-13 | Eastman Kodak Company | Method of providing lithographic printing plates |
DE102009036485B4 (de) * | 2009-08-07 | 2012-10-04 | Lts Lohmann Therapie-Systeme Ag | Mittel zur zerstörenden Entsorgung von medizinischen Wirkstoffen in transdermalen therapeutischen Systemen |
RU2573293C2 (ru) | 2010-03-26 | 2016-01-20 | Филип Моррис Продактс С.А. | Ингибирование раздражающих ощущений при потреблении некурительных табачных продуктов |
US8952038B2 (en) | 2010-03-26 | 2015-02-10 | Philip Morris Usa Inc. | Inhibition of undesired sensory effects by the compound camphor |
EP2729148A4 (en) | 2011-07-06 | 2015-04-22 | Parkinson S Inst | COMPOSITIONS AND METHODS FOR TREATING SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE |
AU2012296346A1 (en) | 2011-08-18 | 2014-04-03 | Biodelivery Sciences International, Inc. | Abuse-resistant mucoadhesive devices for delivery of buprenorphine |
KR20140067042A (ko) | 2011-09-30 | 2014-06-03 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 일반 약물 처리 시스템 |
CA2846956C (en) | 2011-09-30 | 2017-12-12 | Teikoku Pharma Usa, Inc. | Transdermal patch disposal system |
US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
GB201309654D0 (en) | 2013-05-30 | 2013-07-17 | Euro Celtique Sa | Method |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
EP3766463A1 (en) | 2015-02-19 | 2021-01-20 | Candesant Biomedical, Inc. | Medical devices for generating heat and methods of treatment using same |
CA2977814A1 (en) | 2015-03-12 | 2016-09-15 | Chrono Therapeutics Inc. | Craving input and support system |
GB201520390D0 (en) * | 2015-11-19 | 2016-01-06 | Euro Celtique Sa | Composition |
US20170273974A1 (en) | 2016-03-24 | 2017-09-28 | Medrx Co., Ltd | Patch preparations with misuse prevention features |
JPWO2017164084A1 (ja) | 2016-03-24 | 2019-02-07 | 株式会社 メドレックス | 誤用防止特性を有する貼付製剤 |
CA2972220C (en) * | 2016-06-29 | 2023-01-24 | Disposerx, Inc. | Disposal of medicaments |
CA3049529A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
US11510882B2 (en) | 2017-09-22 | 2022-11-29 | Medrx Co., Ltd. | Non-readherable adhesive patch |
US11389844B2 (en) | 2018-03-20 | 2022-07-19 | Verde Environmental Technologies, Inc. | Blister pack disposal system |
JP7420797B2 (ja) | 2018-05-29 | 2024-01-23 | モーニングサイド ベンチャー インベストメンツ リミテッド | 薬剤送達の方法及びシステム |
WO2021119151A1 (en) * | 2019-12-10 | 2021-06-17 | Candesant Biomedical, Inc. | Methods and systems for disposing alkali metal patches |
Family Cites Families (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3527864A (en) | 1966-11-18 | 1970-09-08 | Procter & Gamble | Compositions for topical application to animal tissue and method of enhancing penetration thereof |
US3540580A (en) * | 1967-07-03 | 1970-11-17 | Borden Inc | Heat-seal adhesive and package |
US3472931A (en) | 1969-01-17 | 1969-10-14 | Foster Milburn Co | Percutaneous absorption with lower alkyl amides |
US3903256A (en) | 1972-02-07 | 1975-09-02 | Procter & Gamble | Compositions for topical application of animal tissue and method of enhancing penetration thereof |
US3896238A (en) | 1972-04-05 | 1975-07-22 | Procter & Gamble | Dermatological compositions |
US3952099A (en) | 1973-03-13 | 1976-04-20 | The Procter & Gamble Company | Dermatological compositions |
US4046886A (en) | 1975-01-17 | 1977-09-06 | The Procter & Gamble Company | Dermatological compositions |
US4405616A (en) | 1975-06-19 | 1983-09-20 | Nelson Research & Development Company | Penetration enhancers for transdermal drug delivery of systemic agents |
US3989816A (en) | 1975-06-19 | 1976-11-02 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacycloheptan-2-ones |
US4316893A (en) | 1975-06-19 | 1982-02-23 | Nelson Research & Development Co. | Vehicle composition containing 1-substituted azacycloalkan-2-ones |
US4130667A (en) | 1976-01-12 | 1978-12-19 | The Procter & Gamble Company | Dermatological compositions |
US4060084A (en) | 1976-09-07 | 1977-11-29 | Alza Corporation | Method and therapeutic system for providing chemotherapy transdermally |
US4335115A (en) | 1976-11-01 | 1982-06-15 | The Procter & Gamble Company | Anti-acne composition |
US4166058A (en) * | 1978-08-11 | 1979-08-28 | The Goodyear Tire & Rubber Company | Heat sensitive primer exhibiting color change and containing a resin blend, elemental sulfur, and a dye |
US4326566A (en) | 1979-09-11 | 1982-04-27 | N. V. Weefautomaten Picanol | Color selector |
US4299826A (en) | 1979-10-12 | 1981-11-10 | The Procter & Gamble Company | Anti-acne composition |
US4248748A (en) * | 1980-02-04 | 1981-02-03 | Minnesota Mining And Manufacturing Company | Heat-activated adhesive |
DE3047635A1 (de) * | 1980-12-17 | 1982-07-22 | Hilti AG, 9494 Schaan | Klebeverfahren mittels schmelzklebstoff sowie mittel zur durchfuehrung des verfahrens |
US4379454A (en) | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
US4343798A (en) | 1981-06-23 | 1982-08-10 | The Procter & Gamble Company | Topical antimicrobial anti-inflammatory compositions |
US4560553A (en) | 1981-07-07 | 1985-12-24 | Merck & Co., Inc. | Use of eucalyptol for enhancing skin permeation of bio-affecting agents |
US4510621A (en) * | 1983-06-30 | 1985-04-09 | Arvey Corporation | Self-sealing pouch for forming adhesive-to-adhesive seal |
US4588580B2 (en) | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
JPS61103840A (ja) | 1984-10-26 | 1986-05-22 | Nitto Electric Ind Co Ltd | 外皮投与用組成物 |
US4806341A (en) | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
US5066648A (en) | 1985-11-29 | 1991-11-19 | Merck & Co., Inc. | Pyroglutamic acid esters used as dermal penetration enhancers for drugs |
US4973968A (en) | 1986-03-07 | 1990-11-27 | Plessey Overseas Limited | Radar system for determining first time around targets from multiple time around targets |
US4863970A (en) | 1986-11-14 | 1989-09-05 | Theratech, Inc. | Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols |
US4940586A (en) | 1987-02-26 | 1990-07-10 | Alza Corporation | Skin permeation enhancer compositions using sucrose esters |
US4746515A (en) | 1987-02-26 | 1988-05-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolaurate |
US4879275A (en) | 1987-09-30 | 1989-11-07 | Nelson Research & Development Co. | Penetration enhancers for transdermal delivery of systemic agent |
US5225473A (en) * | 1987-11-25 | 1993-07-06 | Minnesota Mining And Manufacturing Company | Pressure-sensitive adhesives |
GB8811669D0 (en) * | 1988-05-17 | 1988-06-22 | Alcan Int Ltd | Colour-changeable adhesive |
US5164406A (en) | 1988-06-02 | 1992-11-17 | Bristol-Myers Squibb Co. | Method for enhancing transdermal penetration and compositions useful therein |
US5378730A (en) | 1988-06-09 | 1995-01-03 | Alza Corporation | Permeation enhancer comprising ethanol and monoglycerides |
US5641504A (en) | 1988-06-09 | 1997-06-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolinoleate |
US4960771A (en) | 1988-07-12 | 1990-10-02 | Rajadhyaksha Vithal J | Oxazolidinone penetration enhancing compounds |
US5236714A (en) | 1988-11-01 | 1993-08-17 | Alza Corporation | Abusable substance dosage form having reduced abuse potential |
US4956171A (en) * | 1989-07-21 | 1990-09-11 | Paco Pharmaceutical Services, Inc. | Transdermal drug delivery using a dual permeation enhancer and method of performing the same |
US5750134A (en) * | 1989-11-03 | 1998-05-12 | Riker Laboratories, Inc. | Bioadhesive composition and patch |
US5240711A (en) | 1989-11-29 | 1993-08-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system comprising as active component buprenorphine |
US5069909A (en) | 1990-06-20 | 1991-12-03 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine |
JP3196851B2 (ja) * | 1991-04-01 | 2001-08-06 | 積水化学工業株式会社 | 医療用貼付剤 |
US5227169A (en) | 1991-05-17 | 1993-07-13 | Theratech, Inc. | Sorbitan esters as skin permeation enhancers |
US5308887A (en) * | 1991-05-23 | 1994-05-03 | Minnesota Mining & Manufacturing Company | Pressure-sensitive adhesives |
US5149538A (en) | 1991-06-14 | 1992-09-22 | Warner-Lambert Company | Misuse-resistive transdermal opioid dosage form |
US5981666A (en) * | 1991-07-12 | 1999-11-09 | Adhesives Research, Inc. | Method for the production of a high performance pressure sensitive adhesive |
US5232702A (en) * | 1991-07-22 | 1993-08-03 | Dow Corning Corporation | Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices |
US5238933A (en) | 1991-10-28 | 1993-08-24 | Sri International | Skin permeation enhancer compositions |
US5229130A (en) | 1991-12-20 | 1993-07-20 | Cygnus Therapeutics Systems | Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems |
CA2097163C (en) | 1992-06-01 | 2002-07-30 | Marianna Foldvari | Topical patch for liposomal drug delivery system |
US5308625A (en) | 1992-09-02 | 1994-05-03 | Cygnus Therapeutic Systems | Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters |
US6162456A (en) | 1992-09-24 | 2000-12-19 | Ortho-Mcneil Pharmaceutical, Inc. | Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers |
JPH0710742Y2 (ja) * | 1993-02-05 | 1995-03-15 | 日本臓器製薬株式会社 | 救急絆創膏 |
JP3489831B2 (ja) * | 1993-04-20 | 2004-01-26 | ヘクサル・アクチエンゲゼルシャフト | 活性成分パッチ |
US5520385A (en) * | 1993-07-30 | 1996-05-28 | Composite Development Corporation | Article assembled with thermoreponsive material and method |
CA2165802A1 (en) | 1993-09-29 | 1995-04-06 | Eun Soo Lee | Monoglyceride/lactate ester permeation enhancer for oxybutynin |
US5470529A (en) * | 1994-03-08 | 1995-11-28 | Sumitomo Metal Industries, Ltd. | High tensile strength steel sheet having improved formability |
US5420106A (en) | 1994-03-22 | 1995-05-30 | Bristol-Myers Squibb Company | Method and composition having enhanced alpha-hydroxy acid skin permeation and retention |
JP2819236B2 (ja) * | 1994-05-06 | 1998-10-30 | 日東電工株式会社 | 経皮吸収製剤 |
US5540934A (en) | 1994-06-22 | 1996-07-30 | Touitou; Elka | Compositions for applying active substances to or through the skin |
GB9425783D0 (en) * | 1994-12-21 | 1995-02-22 | Ethical Pharma Ltd | Packaging of patches |
US5573778A (en) * | 1995-03-17 | 1996-11-12 | Adhesives Research, Inc. | Drug flux enhancer-tolerant pressure sensitive adhesive composition |
US5882676A (en) | 1995-05-26 | 1999-03-16 | Alza Corporation | Skin permeation enhancer compositions using acyl lactylates |
US5785991A (en) | 1995-06-07 | 1998-07-28 | Alza Corporation | Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate |
US5834468A (en) | 1995-07-07 | 1998-11-10 | Zeneca Limited | Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
WO1997004835A1 (de) * | 1995-07-28 | 1997-02-13 | Novartis Ag | Transdermales system |
US5902603A (en) | 1995-09-14 | 1999-05-11 | Cygnus, Inc. | Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use |
US5837289A (en) | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
ES2191834T3 (es) | 1996-10-24 | 2003-09-16 | Alza Corp | Agentes que facilitan la permeacion y destinados para composiciones, dispositivos y procedimientos de aporte transdermico de medicamentos. |
WO1998018416A1 (en) | 1996-10-30 | 1998-05-07 | Theratech, Inc. | Fatty acid esters of glycolic acid and its salts as permeation enhancers |
DE19649534B4 (de) * | 1996-11-29 | 2004-05-06 | Lts Lohmann Therapie-Systeme Ag | Verpackung aus Verbundpackstoff zum Verpacken von wirkstoffhaltigen Pflastern |
US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
US5804215A (en) * | 1997-03-21 | 1998-09-08 | L. Perrigo Company | Transdermal patch disposal system and method |
US6017983A (en) * | 1998-01-29 | 2000-01-25 | Alpha Metals, Inc. | Color indicator for completion of polymerization for thermosets |
DE19901085C2 (de) * | 1999-01-14 | 2003-12-18 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps |
US7018649B2 (en) * | 2000-10-23 | 2006-03-28 | Euro-Celtique, S.A. | Felodipine transdermal device and methods |
US6682757B1 (en) * | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
DE60235555D1 (de) * | 2001-04-23 | 2010-04-15 | Euro Celtique Sa | Entsorgungssystem für transdermale dosierformen |
PT2062573E (pt) * | 2001-05-01 | 2012-01-11 | Euro Celtique Sa | Sistemas transdérmicos que contêm opióides que resistem a violação |
US6638981B2 (en) * | 2001-08-17 | 2003-10-28 | Epicept Corporation | Topical compositions and methods for treating pain |
-
2003
- 2003-06-10 CN CN200810170710.3A patent/CN101455649B/zh not_active Expired - Fee Related
- 2003-06-10 CA CA2488915A patent/CA2488915C/en not_active Expired - Fee Related
- 2003-06-10 MX MXPA04012333A patent/MXPA04012333A/es active IP Right Grant
- 2003-06-10 JP JP2004510792A patent/JP4949625B2/ja not_active Expired - Fee Related
- 2003-06-10 ES ES03757468T patent/ES2283812T3/es not_active Expired - Lifetime
- 2003-06-10 EP EP03757468A patent/EP1513532B1/en not_active Expired - Lifetime
- 2003-06-10 AT AT03757468T patent/ATE355061T1/de active
- 2003-06-10 EP EP07003694A patent/EP1837023A1/en not_active Ceased
- 2003-06-10 WO PCT/US2003/018256 patent/WO2003103673A1/en active IP Right Grant
- 2003-06-10 AU AU2003251482A patent/AU2003251482A1/en not_active Abandoned
- 2003-06-10 EP EP10179056A patent/EP2266565A1/en not_active Ceased
- 2003-06-10 SI SI200330785T patent/SI1513532T1/sl unknown
- 2003-06-10 CN CNB038135558A patent/CN100525767C/zh not_active Expired - Fee Related
- 2003-06-10 PT PT03757468T patent/PT1513532E/pt unknown
- 2003-06-10 NZ NZ537180A patent/NZ537180A/en not_active IP Right Cessation
- 2003-06-10 DE DE60312160T patent/DE60312160T2/de not_active Expired - Lifetime
- 2003-06-10 EA EA200401564A patent/EA007240B1/ru not_active IP Right Cessation
- 2003-06-10 DK DK03757468T patent/DK1513532T3/da active
- 2003-06-10 US US10/457,562 patent/US20040033255A1/en not_active Abandoned
- 2003-06-10 KR KR1020047020117A patent/KR101407131B1/ko active IP Right Grant
- 2003-06-10 EP EP10010605A patent/EP2298302A1/en not_active Ceased
- 2003-06-10 KR KR1020117022754A patent/KR20110120358A/ko not_active Application Discontinuation
- 2003-10-06 UA UAA200500155A patent/UA82194C2/uk unknown
-
2004
- 2004-11-24 ZA ZA200409495A patent/ZA200409495B/xx unknown
- 2004-12-02 IL IL16551704A patent/IL165517A0/xx unknown
-
2005
- 2005-01-10 NO NO20050126A patent/NO334455B1/no not_active IP Right Cessation
-
2007
- 2007-05-17 CY CY20071100668T patent/CY1107630T1/el unknown
-
2008
- 2008-07-15 US US12/173,451 patent/US20080274168A1/en not_active Abandoned
-
2009
- 2009-09-18 AU AU2009217420A patent/AU2009217420B2/en not_active Ceased
-
2010
- 2010-07-12 JP JP2010158074A patent/JP5507367B2/ja not_active Expired - Lifetime
-
2014
- 2014-01-08 JP JP2014001693A patent/JP5898242B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL165517A0 (en) | Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein | |
AU2003262674A1 (en) | Active agent delivery system including a poly(ethylene-co-(meth)acrylate), medical device, and method | |
WO2003096726A3 (en) | Method and apparatus for use in securing an electronic device such as a cell phone | |
WO2005011586A3 (en) | Treatment and preventi0n of cardiovascular events | |
WO2006055429A3 (en) | Method and apparatus for dynamically activating/deactivating an operating system | |
MY113685A (en) | Transdermal device for the delivery of flurbiprofen | |
WO1996008229A3 (en) | Matrix for transdermal drug delivery | |
WO1999055286A3 (en) | Drug-containing transdermal patches, plastisols and adhesives | |
WO2005011772A3 (en) | Implantable or insertable medical devices containing radiation-treated polymer for improved delivery of therapeutic agents | |
BR0016723A (pt) | Processo para a polimerização de olefinas, em particular para a copolimerização de propileno com pelo menos uma olefina adicional, composto, sistema de catalisador, usos do composto e do sistema, processo para preprar uma poliolefina, homopolìmero ou copolìmero randÈmico de propileno, copolìmero de propileno de alto impacto, uso do mesmo, e, copolìmero de propileno-etileno randÈmico | |
WO2007012012A3 (en) | Medical devices containing sterilisation radiation resistant phenoxy polymers | |
DE60026065D1 (de) | Elektropolymerisierbare monomere und polymerbeschichtungen auf implantierbaren geräten | |
WO2005002193A3 (en) | Video conferencing apparatus and method | |
EP0887074A3 (en) | Intravaginal drug delivery device | |
MXPA06002811A (es) | Metodos y aparato para proteccion de contenido en una red inalambrica. | |
WO2005018702A3 (en) | Active agent delivery systems including a miscible polymer blend, medical devices, and methods | |
EP1025843A3 (en) | Pressure sensitive adhesive compositions for transdermal drug delivery devices | |
EP1108770A3 (en) | Removable pressure-sensitive adhesive sheet | |
GB2397910B (en) | Methods and apparatus for rapidly activating inactive components in a computer system | |
EP1282028A3 (en) | Method and apparatus for locking an application within a trusted computing environment | |
MXPA04001676A (es) | Sistema terapeutico transdermico con fentanilo o sustancias relacionadas. | |
WO2002075527A3 (en) | Dynamically downloading and executing system services on a wireless device | |
EP1829898A4 (en) | SOLID CATALYST COMPONENT AND CATALYST FOR POLYMERIZING OLEFIN AND METHOD FOR PRODUCING OLEFINE POLYMER OR COPOLYMER THEREWITH | |
WO2008115811A3 (en) | Transdermal delivery form disposal systems and methods | |
AU8602201A (en) | Complexing structure, device and method for treating liquid effluents |